Clomipramine and Doxepin in Depressive Neurosis
- 1 November 1980
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 37 (11) , 1295-1299
- https://doi.org/10.1001/archpsyc.1980.01780240093011
Abstract
• The therapeutic efficacy, plasma levels, and psychomotor effects of tryptophan (L-tryptophan), clomipramine hydrochloride, and doxepin were investigated in "neurotically" depressed outpatients. The tricyclic antidepressants were significantly more efficacious than tryptophan in inducing remission. The alleviation of depression was preceded by an improvement of the initially slow information-processing rates in the depressed patients. The plasma levels of the tricyclics that were associated with a therapeutic response were significantly lower than those reported in "endogenously" depressed inpatients.This publication has 14 references indexed in Scilit:
- Plasma and erythrocyte levels of tricyclic antidepressants in depressed patientsAmerican Journal of Psychiatry, 1978
- Protriptyline plasma levels and antidepressant responseClinical Pharmacology & Therapeutics, 1977
- Comparative clinical evaluation of lofepramine and imipramineActa Psychiatrica Scandinavica, 1977
- Nortriptyline plasma levels and therapeutic responseClinical Pharmacology & Therapeutics, 1976
- PLASMA-NORTRIPTYLINE LEVELS IN ENDOGENOUS DEPRESSIONThe Lancet, 1973
- PLASMA CONCENTRATION OF NORTRIPTYLINE AND CLINICAL RESPONSE IN DEPRESSIVE ILLNESSThe Lancet, 1972
- Monoamine precursors in the treatment of depressionClinical Pharmacology & Therapeutics, 1971
- Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compoundsLife Sciences, 1967
- An Inventory for Measuring DepressionArchives of General Psychiatry, 1961
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960